Stocks in Action USA: Kura Oncology, Haemonetics, and Alibaba.
Reading Time: 3 minutes
Kura Oncology (KURA): CEO Purchase Over $1.1 Million Boosts Confidence in KOMZIFTI! Kura Oncology is in the spotlight for investors following a million-dollar insider purchase by CEO Troy Wilson. Wilson acquired 100,000 shares at an average price of $11.12 through a family trust he controls, investing approximately $1.1 million from the open market – a clear signal from management after the recent quarterly results. At the same time, the commercial flagship product KOMZIFTI is showing dynamic growth: Revenue in the second quarter rose to $9.1...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
